BG
RGNX icon

Bellevue Group’s Regenxbio RGNX Stock Holding History

Bellevue Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,000
Closed -$253K – 173
2024
Q1 		$253K Buy
+12,000
New +$214K ﹤0.01% 151
2020
Q3 		– Sell
-41,000
Closed -$1.51M – 221
2020
Q2 		$1.51M Buy
41,000
+4,100
+11% +$153K 0.02% 140
2020
Q1 		$1.2M Buy
36,900
+16,000
+77% +$667K 0.02% 140
2019
Q4 		$856K Sell
20,900
-12,800
-38% -$506K 0.01% 151
2019
Q3 		$1.2M Buy
33,700
+600
+2% +$24.3K 0.02% 138
2019
Q2 		$1.7M Hold
33,100
– – 0.03% 134
2019
Q1 		$1.9M Buy
33,100
+9,800
+42% +$485K 0.1% 111
2018
Q4 		$977K Hold
23,300
– – 0.06% 116
2018
Q3 		$1.76M Sell
23,300
-500
-2% -$36K 0.11% 107
2018
Q2 		$1.71M Buy
+23,800
New +$1.14M 0.15% 94

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return